Camidge, D Ross <br/><br/>
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.  [electronic resource] 

 -  The Lancet. Oncology  01 2018 
 - e20-e32 p.  digital 
<br/><br/> Publication Type: Journal Article; Practice Guideline; Review 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(17)30693-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Brain Neoplasms--drug therapy<br/>Clinical Trials as Topic--methods<br/>Endpoint Determination--standards<br/>Humans<br/>Patient Selection<br/>Treatment Outcome